Investors Five-year Losses Continue as Urovo Technology (SZSE:300531) Dips a Further 15% This Week, Earnings Continue to Decline
Investors Five-year Losses Continue as Urovo Technology (SZSE:300531) Dips a Further 15% This Week, Earnings Continue to Decline
Generally speaking long term investing is the way to go. But that doesn't mean long term investors can avoid big losses. Zooming in on an example, the Urovo Technology Co., Ltd. (SZSE:300531) share price dropped 52% in the last half decade. We certainly feel for shareholders who bought near the top. And some of the more recent buyers are probably worried, too, with the stock falling 32% in the last year. Shareholders have had an even rougher run lately, with the share price down 27% in the last 90 days.
一般而言,长期投资是必经之路。但这并不意味着长期投资者可以避免巨额损失。举一个例子,Urovo科技有限公司(深圳证券交易所代码:300531)的股价在过去五年中下跌了52%。对于在接近顶部买入的股东,我们当然有同感。一些最近的买家可能也感到担忧,该股去年下跌了32%。股东们最近的表现更加艰难,股价在过去90天中下跌了27%。
Since Urovo Technology has shed CN¥644m from its value in the past 7 days, let's see if the longer term decline has been driven by the business' economics.
由于Urovo Technology在过去7天内已从其价值中减少了6.44亿元人民币,因此让我们看看长期下跌是否是由该业务的经济推动的。
To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.
用本杰明·格雷厄姆的话来说:从短期来看,市场是一台投票机器,但从长远来看,它是一台称重机。评估公司情绪变化的一种有缺陷但合理的方法是将每股收益(EPS)与股价进行比较。
During the five years over which the share price declined, Urovo Technology's earnings per share (EPS) dropped by 2.1% each year. Readers should note that the share price has fallen faster than the EPS, at a rate of 14% per year, over the period. This implies that the market is more cautious about the business these days.
在股价下跌的五年中,Urovo Technology的每股收益(EPS)每年下降2.1%。读者应注意,在此期间,股价的下跌速度快于每股收益,每年下降14%。这意味着如今市场对该业务更加谨慎。
The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).
该公司的每股收益(随着时间的推移)如下图所示(点击查看确切数字)。
It might be well worthwhile taking a look at our free report on Urovo Technology's earnings, revenue and cash flow.
可能值得一看我们关于Urovo Technology收益、收入和现金流的免费报告。
A Different Perspective
不同的视角
We regret to report that Urovo Technology shareholders are down 32% for the year (even including dividends). Unfortunately, that's worse than the broader market decline of 13%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 9% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Consider risks, for instance. Every company has them, and we've spotted 1 warning sign for Urovo Technology you should know about.
我们遗憾地报告,Urovo Technology的股东今年下跌了32%(甚至包括股息)。不幸的是,这比整个市场13%的跌幅还要严重。话虽如此,在下跌的市场中,一些股票不可避免地会被超卖。关键是要密切关注基本发展。遗憾的是,去年的业绩结束了糟糕的表现,股东在五年内每年面临9%的总亏损。总的来说,长期股价疲软可能是一个坏兆头,尽管逆势投资者可能希望研究该股以期出现转机。尽管市场状况可能对股价产生的不同影响值得考虑,但还有其他因素更为重要。例如,考虑风险。每家公司都有它们,我们发现了你应该知道的关于Urovo Technology的1个警告标志。
For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.
对于那些喜欢寻找中奖投资的人来说,这份最近有内幕收购的成长型公司的免费名单可能只是门票。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.
请注意,本文引用的市场回报反映了目前在中国交易所交易的股票的市场加权平均回报。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。